Cinryze: Drug Insights 2018-2022 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jul 30, 2018--The “Cinryze - Drug Insights, 2018” report has been added to ResearchAndMarkets.com’s offering.
This report provides comprehensive information of the drug, Cinryze. It includes Cinryze’s overview, mechanism, clinical trials, regulatory milestones, deals & partnerships. It further provides Cinryze’s patents (US & EU). It also features the historical and forecasted sales of Cinryze till 2022.
The report also throws light on Cinryze’s market competition and emerging therapies in the same space as Cinryze. A SWOT analysis of the drug is also featured.
Overview of development activities around CinryzeThe segment comprises of detailed description of the product especially highlighting its regulatory milestones, research and development, deals & partnerships, patent and technology details Global Sales Assessment and analysis of market competition Graphical representation of historical and forecasted global sales of Cinryze till 2022 and marked attention on the current market competition and upcoming emerging therapies in the same space
ScopeA comprehensive product overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report Patent information around Cinryze in the United States (US) and Europe (EU) has been highlighted The report contains historical and forecasted sales for Cinryze till 2022 Comprehensive coverage of the emerging therapies (Phase III) in the space where Cinryze operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information The report also features the SWOT analysis of Cinryze
Key Topics CoveredIntroduction Cinryze - Overview Product Description Dosage and Strengths Route of Synthesis Mechanism of Action Pharmacology Pharmacodynamics Pharmacokinetics Adverse Reactions Clinical Studies Adolescent & Adult Study Results Pediatric Study Results Other Pipeline Activity Regulatory Milestones European Market Approval United States Approval Supplemental Biologics License Application (sBLA) Acquisition Technology Designation Agreement Technology Transfer Marketed Details United States Europe Cinryze Sales Assessment Global Analyst Insights Patent Details Global API Manufacturers India Market Competitors Emerging Therapies SWOT Analysis Appendix
For more information about this report visit https://www.researchandmarkets.com/research/4bdgql/cinryze_drug?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180730005612/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Immune Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 07/30/2018 12:54 PM/DISC: 07/30/2018 12:54 PM